XML 57 R37.htm IDEA: XBRL DOCUMENT v3.26.1
Restatement of Previously Issued Audited Financial Statements (Tables)
 12 Months Ended
Dec. 31, 2025
Restatement of Previously Issued Audited Financial Statements [Abstract]  
Schedule of Restated Balance Sheet

 
The tables below set forth the effect on the various financial statement captions including the balances originally reported and the restated balances as of December 31, 2024.

 

Balance Sheet  As
Previously
Reported		   Adjustments   As Restated 
Warrant liability   15,012,361    12,691,566    27,703,927 
Total liabilities   18,501,699    12,641,566    31,143,265 
Additional paid-in capital   200,863,551    (8,558,271)   192,305,280 
Accumulated deficits   (189,269,903)   (4,083,295)   (193,353,198)
Total stockholders’ equity (deficit)   11,593,650    (12,641,566)   (1,047,916)
Schedule of Restated Statements of Operations
Statement of Operations  As
Previously
Reported		   Adjustments   As Restated 
Warrant liability issuance costs   0    (1,739,148)   (1,739,148)
Loss on issuance of warrants   0    (2,344,147)   (2,344,147)
Total other income (expenses), net   (6,424,209)   (4,083,295)   (10,507,504)
Net loss   (29,252,284)   (4,083,295)   (33,335,579)
Net loss per share attributable to common stockholders, basic and diluted   (2,212.56)   (308.85)   (2,521.41)
Schedule of Restated Statement of Stockholders’ Equity (Deficit)
Statement of Stockholders’ Equity (Deficit)  As
Previously
Reported		   Adjustments   As Restated 
Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings   20,972,722    (8,558,270)   12,414,453 
Net loss   (29,252,284)   (4,083,295)   (33,335,579)
Schedule of Restated Statement of Cash Flows
Statement of Cash Flows  As
Previously
Reported		   Adjustments   As Restated 
Net loss   (29,252,284)   (4,083,295)   (33,335,579)
Loss on issuance of warrants   0    2,344,147    2,344,147 
Warrant issuance costs   0    1,739,148    1,739,148 
Accrued expenses, lease liabilities, and other current liabilities   10,642,938    (9,652,581)   990,357 
Net cash used in operating activities   9,493,500    9,702,581    19,196,081 
Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants   22,369,285    (8,558,271)   13,811,014 
Proceeds from issuance of warrants   0    18,260,852    18,260,852 
Net cash provided by financing activities   26,584,380    9,702,581    36,286,961 
Schedule of Balance Sheet and Cash Flows
Balance Sheet  As
Previously
Reported		   Adjustments   As Restated 
Accounts Payable   297,778    (50,000)   247,778 

 

Statement of Cash Flows  As
Previously
Reported		   Adjustments   As Restated 
Accounts Payable   100,815    (50,000)   50,815